Brief: Gilead Sciences Reports 19.9% Passive Stake In Xilio Therapeutics As Of March 27 - SEC Filing
05/04/2024 22:39
April 5 (Reuters) - Gilead Sciences Inc GILD.O :
* GILEAD SCIENCES, INC REPORTS 19.9% PASSIVE STAKE IN XILIO
THERAPEUTICS AS OF MARCH 27 - SEC FILING
Source text for Eikon: [ID:https://bitly.ws/3hv9r]
Further company coverage: GILD.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Xilio Therapeutics
See all newsXilio Therapeutics Inc reports results for the quarter ended June 30 - Earnings Summary
Xilio Therapeutics Inc expected to post a loss of 92 cents a share - Earnings Preview
Brief: Xilio Therapeutics Reports Second Quarter 2026 Financial Results And Provides Pipeline And Business Updates
U.S. STOCKS ON THE MOVE-Palantir, AeroVironment, Valvoline
U.S. STOCKS ON THE MOVE-Medtronic, AeroVironment, Tesla